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Histone post-translational modifications regulate chromatin structure and function largely through interactions
with effector proteins that often contain multiple histone-binding domains. While significant progress has been
made characterizing individual effector domains, the role of paired domains and how they function in
a combinatorial fashion within chromatin are poorly defined. Here we show that the linked tandem Tudor and
plant homeodomain (PHD) of UHRF1 (ubiquitin-like PHD and RING finger domain-containing protein 1) operates
as a functional unit in cells, providing a defined combinatorial readout of a heterochromatin signature within
a single histone H3 tail that is essential for UHRF1-directed epigenetic inheritance of DNA methylation. These
findings provide critical support for the ‘‘histone code’’ hypothesis, demonstrating that multivalent histone
engagement plays a key role in driving a fundamental downstream biological event in chromatin.
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Histone post-translational modifications (PTMs) and
DNA methylation are two key epigenetic regulators of
DNA information in chromatin. The N-terminal and
C-terminal tails of histones are rich in PTMs, including
methylation, acetylation, phosphorylation, and ubiquiti-
nation (Kouzarides 2007; Tan et al. 2011). Histone PTMs
have been shown to alter the physical structure of
chromatin (Shogren-Knaak et al. 2006) and may function
in the form of a ‘‘histone code’’ to facilitate the binding of
effector proteins that elicit selective effects on chroma-
tin-templated biological processes like gene expression
and DNA repair (Strahl and Allis 2000; Jenuwein and
Allis 2001; Taverna et al. 2007).
Effector proteins associate with (i.e., ‘‘read’’) specific
PTMs and surrounding residues on histone tails through
specialized recognition domains (Taverna et al. 2007;
Musselman et al. 2012a). To date, a wide number of
reader domains have been characterized and include
modules that bind acetyllysine (e.g., bromodomains),
methyllysine (e.g., chromo, Tudor, plant homeodomain
[PHD], PWWP, and MBT domains), methylarginine (e.g.,
Tudor domains), phosphoserine (e.g., 14-3-3 and BRCT
domains), and even unmodified histone residues (e.g.,
ADD and PHD domains) (Taverna et al. 2007; Musselman
et al. 2012a). Although many chromatin-associated pro-
teins encode only a single reader module, a significant
number of these proteins in fact contain multiple chro-
matin recognition domains or are partnered with other
effector proteins containing one or more reader modules
through membership in macromolecular complexes. Thus,
multivalent chromatin engagement is likely to be an
important aspect of how chromatin-associated proteins
function—a concept suggested by the ‘‘histone code’’
hypothesis (Strahl and Allis 2000; Jenuwein and Allis
2001; Ruthenburg et al. 2007). Indeed, several examples of
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multivalent histone engagement by effector proteins
have recently been described (Tsai et al. 2010; Eustermann
et al. 2011; Ruthenburg et al. 2011; Xi et al. 2011; Ali et al.
2012; Musselman et al. 2012b; Oliver et al. 2012; Qiu et al.
2012). However, the contribution of these combinatorial
interactions to the biological functions associated with
these proteins remains poorly defined.
The E3 ubiquitin ligase UHRF1 (ubiquitin-like PHD
and RING finger domain-containing protein 1) is a unique
chromatin effector protein in that it integrates the rec-
ognition of both histone PTMs and DNA methylation
(Arita et al. 2008; Avvakumov et al. 2008; Hashimoto
et al. 2008; Nady et al. 2011; Rajakumara et al. 2011). As
such, UHRF1 harbors multiple domains that bind chro-
matin (Fig. 1A). The UHRF1 SET and RING-associated
(SRA) domain is a DNA-binding domain that recognizes
5-methylcytosine (5mC) and 5-hydroxymethylcytosine in
the context of hemimethylated double-stranded CpG
dinucleotides (Arita et al. 2008; Avvakumov et al. 2008;
Hashimoto et al. 2008; Qian et al. 2008; Frauer et al. 2011;
Spruijt et al. 2013). DNA methylation patterns are estab-
lished during early embryogenesis by de novo DNA
methyltransferases DNMT3a and DNMT3b (with the
associated, but noncatalytic, DNMT3L) (Okano et al.
1999; Bourc’his et al. 2001; Jia et al. 2007) and are primarily
maintained through somatic cell divisions by the mainte-
nance DNA methyltransferase DNMT1 (Chen et al. 2007).
Genetic studies have demonstrated that UHRF1 is essen-
tial for faithful DNMT1-mediated maintenance methyla-
tion (Bostick et al. 2007; Sharif et al. 2007), and our
laboratory determined that the DNA methylation main-
tenance function of UHRF1 is linked to its ability to engage
di- and trimethylated H3K9 (H3K9me2/3)—transcriptionally
repressive chromatin marks enriched at pericentric het-
erochromatin and telomeres (Ebert et al. 2006; Grewal
and Elgin 2007; Hawkins et al. 2010; Ernst et al.
2011)—through the first Tudor subdomain of its tan-
dem Tudor domain (TTD) (Fig. 1A,B; Nady et al. 2011;
Rothbart et al. 2012a). The adjacent PHD of UHRF1 (Fig.
1A), previously implicated in the regulation of transcrip-
tion (Rajakumara et al. 2011) and heterochromatin orga-
nization (Papait et al. 2007), binds the unmodified N
terminus of histone H3 (Fig. 1B; Hu et al. 2011; Rajakumara
et al. 2011; Wang et al. 2011). Crystal structures of the
linked TTD–PHD bound to H3K9me3 peptides show that
UHRF1 can simultaneously engage the unmodified H3 N
terminus and H3K9me3 on a single H3 tail (cis recogni-
tion) through this linked recognition module (Fig. 1C;
Arita et al. 2012; Cheng et al. 2013), although the UHRF1
TTD and PHD are able to bind histone peptides indepen-
Figure 1. PHD function is critical for UHRF1
TTD–PHD binding in vitro. (A) Domain map of
full-length UHRF1. Positions of alanine muta-
tions used in this study are indicated with
asterisks. Brackets demarcate the histone-bind-
ing module (amino acids 123–366). (B) Surface
representations of the UHRF1 TTD (left; PDB:
2L3R) (Nady et al. 2011) and UHRF1 PHD
(right; PDB: 3SOU) (Rajakumara et al. 2011)
bound to H31–11K9me3 and H31–8 peptides,
respectively. This H3K9me3–TTD interaction
is referred to throughout the manuscript as the
alternative H3-binding pose with respect to the
TTD. (C) Surface representation of the UHRF1
TTD–PHD (PDB: 3ASK) bound to H31–11K9me3
peptides. (D) Representative subarrays of pep-
tide microarray scans for the UHRF1 TTD–
PHD. Peptides (green) are spotted in triplicate
four times per subarray (two subarrays per slide)
and protein binding (red) was detected as de-
scribed in the Materials and Methods. (TTD
mutant) UHRF1 TTD–PHD Y188A; (PHD mu-
tant) UHRF1 TTD–PHD D334A/E335A. (E)
Scatter plot of normalized mean intensities
from two peptide microarrays probed with
wild-type UHRF1 TTD–PHD. Each spot repre-
sents an individual peptide (see Supplemental
Table S1 for a full peptide list) and is color-coded
by histone as described in the key. (F) Scatter
plot of normalized mean intensities (five arrays
for wild-type [WT] and three arrays for TTD
mutant) for H3 peptides on the array. Each spot
represents an individual peptide and is color-
coded as described in the key. (G) Heat map
depicting the effects of single PTMs on the binding of wild-type UHRF1 TTD–PHD to H31–20 peptides. Normalized mean intensities are
represented relative to unmodified H31–20 (0, white). Enhanced (1, blue) and perturbed (1, red) interactions are depicted.
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dently of one another in vitro (Fig. 1B; Hu et al. 2011;
Nady et al. 2011; Rajakumara et al. 2011; Wang et al. 2011).
However, it remains to be determined whether multiva-
lent engagement of H3 by the linked reader modules of
UHRF1 is biologically significant.
Here, we comprehensively characterize the specificity,
selectivity, and molecular dynamics of the TTD–PHD
dual-effector module of UHRF1. Notably, we demonstrate
that this structural unit functions as a single histone
recognition module in cells, providing a combinatorial
readout of a histone H3 tail in cis that is required for the
epigenetic inheritance of DNA methylation. Our findings
are among the first to demonstrate that multivalent
histone engagement in a defined manner plays a funda-
mental role in driving a downstream biological event in
chromatin, providing critical support for the combinato-
rial nature of the ‘‘histone code’’ hypothesis.
Results
The UHRF1 PHD dominates multivalent histone
H3 engagement in vitro
To decipher the contribution of the ‘‘histone code’’ on
effector protein recognition, we recently developed
a high-density (>4000 features) peptide microarray plat-
form harboring a comprehensive library of known single
and combinational PTMs on each of the core histone
proteins (H3, H4, H2A, and H2B) (Supplemental Table S1;
Fuchs et al. 2011; Rothbart et al. 2012b). This technology
was recently used to define the isolated UHRF1 TTD as
a bona fide H3K9 di- and trimethyl reader module (Fig. 1B)
and also uncovered a novel and biologically relevant
property of the UHRF1 TTD as an H3K9 effector domain
that is insensitive to neighboring H3S10 phosphorylation
(H3S10p) (Rothbart et al. 2012a). In addition to the TTD,
UHRF1 contains an adjacent PHD finger that interacts
with the unmodified N terminus of H3 (Fig. 1B; Hu et al.
2011; Rajakumara et al. 2011; Wang et al. 2011). Recent
structural studies indicated that the linked TTD and
PHD domains of UHRF1 simultaneously bind H3K9me3
peptides on a single histone tail in vitro (Fig. 1C; Arita et al.
2012; Cheng et al. 2013). We therefore sought to character-
ize this multivalent cis interaction further in the context of
the ‘‘histone code’’ and asked whether such binding is
biologically important for UHRF1 function in the cell.
Peptide microarrays probed with the wild-type UHRF1
TTD–PHD revealed a strong preference for histone H3
peptides encompassing the N-terminal tail (Fig. 1D,E;
Supplemental Fig. S1A). Notably, an aromatic cage mu-
tation of the UHRF1 TTD (Y188A; TTD mutant), pre-
viously shown to abolish the interaction with H3K9
methylation (Nady et al. 2011), showed interactions sim-
ilar to those found with the wild-type dual domain, with
the exception that a number of H3K9 methylated pep-
tides that were ‘‘strong’’ hits in the wild-type case
(Supplemental Fig. S1B) were shifted slightly to a lower
range of detection (Fig. 1D,E). In striking contrast, alanine
mutations at two acidic residues in the UHRF1 PHD
(D334A/E335A; PHD mutant) (Rajakumara et al. 2011),
previously shown to strongly inhibit the isolated PHD
interaction with N-terminal H3 tail peptides (Rajakumara
et al. 2011), completely disrupted array binding, even in
the presence of a functional TTD (Fig. 1D). Consistent with
an important role for the N terminus of H3 in TTD–PHD
binding, PTMs at the extreme N terminus of H3, including
asymmetric Arg 2 methylation or citrullination (H3R2me2a
and Cit2, respectively), Thr 3 phosphorylation (H3T3p), and
Lys 4 acetylation (H3K4ac), strongly perturbed binding of
the wild-type UHRF1 TTD–PHD (Fig. 1F,G). Interestingly,
while array analysis showed a slight inhibitory effect in the
presence H3K4me3, in-solution peptide pull-down and
isothermal titration calorimetry (ITC) analysis indicated
that this change was not significant (data not shown). Col-
lectively, these data suggest that the UHRF1 PHD provides
a dominant affinity for the unmodified N terminus of H3,
while the TTD facilitates the localization of UHRF1 to
H3K9me2/3-marked chromatin.
Quantitative analysis of UHRF1 TTD–PHD binding
to H3K9me3 reveals individual domain contributions
to multivalency
While peptide microarray analysis is a powerful tool for
discriminating between strong and weak binding events,
the technology is limited to semiquantitative measures.
To further define the contributions of the UHRF1 TTD
and PHD to multivalent engagement, we sought to
quantify binding events using fluorescence polarization.
The UHRF1 TTD–PHD bound tightly to H31–20K9me2
(Kd ;0.17 mM) and H31–20K9me3 (Kd ;0.35 mM) peptides
fluorescently labeled at the C terminus (Fig. 2A; Supple-
mental Fig. S1C), consistent with Kd measurements for
H3K9me3 peptides by ITC (Arita et al. 2012). Perturbing
the TTD interaction with H3K9 methylation (Y188A;
TTD mutant) diminished the affinity for these peptides
10-fold to 15-fold (Kd ;2.5 and 4.5 mM, respectively) (Fig.
2A; Supplemental Fig. S1C). Consistent with microarray
results, perturbing the PHD interaction with the N ter-
minus of H3 (D334A/E335A; PHD mutant) resulted in
undetectable binding to H31–20K9me2 and H31–20K9me3
peptides fluorescently labeled at the C terminus (Fig. 2A;
Supplemental Fig. S1C).
Many effector modules that recognize the extreme
N terminus of H3 (residues 1–4)—including the UHRF1
PHD—specifically interact with the N-terminal amino
group of Ala 1. Therefore, we predicted that placement of
a fluorescent probe on the N terminus of H31–20K9me3
peptides would block PHD interaction with the free N
terminus. Indeed, N-terminal probe placement resulted
in no detectable binding to wild-type UHRF1 TTD–PHD
or to the individual domain mutants of this dual binding
module (Fig. 2A). These results agree with those of Arita
et al. (2012), in which no measurable binding of wild-type
UHRF1 TTD–PHD was detected by ITC to H3K9me3 pep-
tides acetylated at their N-terminal amino group. Further-
more, binding of the UHRF1 TTD–PHD to H31–20K9me3
peptides fluorescently labeled at the C terminus was out-
competed by unlabeled H31–5 peptides containing either
L-alanine or L-valine at position 1 but not with unlabeled
Rothbart et al.
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H31–5 peptides containing either D-alanine or D-valine,
demonstrating that stereochemistry at the first position
is critical for PHD binding and that the functional PHD
is likely able to accommodate more bulky side chains
(Supplemental Fig. S1D).
Collectively, these results demonstrate that the high-
affinity interaction of the UHRF1 TTD–PHD for H3K9me2
and H3K9me3 peptides requires multivalent engagement
of H3K9 methylation by the UHRF1 TTD and the H3 N
terminus by the UHRF1 PHD. Furthermore, the UHRF1
TTD–PHD cannot maintain a measurable interaction
with H3K9me2/3 in the absence of a functional PHD
that interacts with the H3 N terminus, while TTD–PHD
affinity for H3K9me2/3 peptides is reduced ;10-fold in
the absence of a functional methyllysine binding pocket
within the TTD (Fig. 2A).
The UHRF1 PHD–linker fragment physically
occludes alternative H3 peptide-binding poses
with the UHRF1 TTD
Strong experimental evidence shows that the UHRF1
TTD can function as a H3K9me2/3 reader domain in
isolation (Supplemental Fig. S1E; Nady et al. 2011; Arita
et al. 2012; Rothbart et al. 2012a; Cheng et al. 2013), but
our data demonstrate that in the context of the dual do-
main, the TTD has no measurable affinity for H3K9me2/3
peptides in the absence of PHD function. This led us to
question why the physical linkage of the TTD to the PHD
finger renders this H3K9 reader domain incapable of
engaging H3K9 methylated histone tails in the absence
of PHD coordination of the H3 N terminus. In the crystal
structure of the UHRF1 TTD–PHD bound to H3K9me3
(Protein Data Bank [PDB]: 3ASK) (Arita et al. 2012), the
15-amino-acid region (linker) connecting the TTD and
PHD domains (amino acids 286–300) resides in the same
binding groove occupied by the H3 peptide in the solution
structure of the isolated UHRF1 TTD (PDB: 2L3R) (Fig.
1B,C; Nady et al. 2011). Here, we refer to this H3–TTD
interaction (PBD: 2L3R) (Nady et al. 2011) as an alterna-
tive H3-binding pose with respect to the TTD. Nuclear
magnetic resonance (NMR) titration of the 15-residue
TTD–PHD linker peptide confirms its interaction with
the alternate H3 peptide-binding groove of the free TTD
(Fig. 3F,G; Supplemental Fig. S4A), and ITC indicates that
this intrinsic affinity of the free linker peptide for the
TTD is weak (>100 mM) in the absence of covalent inter-
action in the intact protein (Supplemental Fig. S4B).
Mutations of R295 and R296 or phosphorylation of
S298, both of which disrupt the linker–TTD interaction,
were previously suggested to uncouple the cooperative
binding potential of the UHRF1 TTD from the PHD in
the context of the dual domain (Arita et al. 2012). Con-
sistent with these findings, a mutant of the linker region
within the TTD–PHD (R295A/R296A) was able to bind
H31–20K9me3 peptides fluorescently labeled at both the
N and C termini (Fig. 2B). This supports a model in which
dissociation of the linker from the TTD allows the al-
ternate mode of H3 peptide binding with the TTD, an
interaction that does not involve the N terminus of H3
and is therefore not affected by the N-terminal fluores-
cent probe. This model also predicts that linker occu-
pancy of the TTD peptide-binding groove would prevent
the TTD from binding H3K9me2/3 peptides in the alter-
native pose (Fig. 1B). To test this predicted occlusion
function of the linker region, we compared the binding
affinity of N-terminally labeled H3K9me3 peptides (which
Figure 2. High-affinity interaction of UHRF1 with H3K9me3
peptides requires multivalent TTD and PHD engagement in cis.
(A,B) Fluorescence polarization binding assays of H31–20K9me3
peptides labeled with 5-carboxyfluorescein (5-FAM) at the N
terminus (red) or C terminus (blue) with the indicated wild-type
(WT) and mutant UHRF1 TTD–PHD proteins. Error bars represent
SD for three independent experiments. All Kd values were deter-
mined using a one-site binding model as described in the Materials
and Methods. Asterisk in B indicates that Kd is likely an average
contribution of two binding sites as suggested by published ITC-
binding stoichiometry calculations (n-value) (Arita et al. 2012). (n.m)
Not measurable; (TTD mutant) UHRF1 TTD–PHD Y188A; (PHD
mutant) UHRF1 TTD–PHD D334A/E335A; (linker mutant) UHRF1
TTD–PHD R295A/R296A. Cartoons depict predicted peptide-
binding modes for wild-type (A, top panel) and Linker mutant
(B) UHRF1 TTD–PHD based on experimental observations.
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can only bind the TTD in the alternative pose) with the
TTD–PHD dual domain and with a protein fragment
containing just the TTD and linker sequence (TTD–linker)
and compared the latter with the disruptive R295A/R296A
mutation in the linker region (TTD–linkermut) (Fig. 3A).
Surprisingly, unlike the TTD–PHD dual domain, the
TTD–linker was able to bind N-terminally tagged
H3K9me3, and this interaction was enhanced by the
Figure 3. The UHRF1 linker–PHD physically occludes TTD coordination of H3K9 methylated peptides in alternative binding poses. (A)
Fluorescence polarization binding assays of N-terminal 5-FAM-H31–20K9me3 peptides with wild-type (WT; black) and linker mutant (blue)
UHRF1 TTD–linker (amino acids 123–301) or wild-type UHRF1 TTD–PHD (red). Error bars represent SD for three independent experiments.
Kd values were determined using a one-site binding model as described in the Materials and Methods. (TTD–linkermut) UHRF1 TTD–linker
R295A/R296A. (B) Estimate of the free-energy landscape in the TTD–PHD molecular dynamics simulation with several representative
conformations. An H31–11K9me3 peptide (yellow) is modeled into the structure in the isolated TTD peptide-binding pose as a point of
reference. The linker region (amino acids 286–301) is depicted as a white ribbon. Contours on the free energies are drawn every 4kbT, where
kb is the Boltzmann constant and T is the temperature. (C) Estimate of the free-energy landscape in the TTD–linker (amino acids 123–301)
molecular dynamics simulation. Contours on the free energies are drawn every 4kbT, where kb is the Boltzmann constant and T is the
temperature. (D) An overlay of linker (left) and R295 (right) conformations for the TTD–PHD (gray) and TTD–linker (red) molecular
dynamics simulations. An H31–11K9me3 peptide (yellow) is modeled into the structure in the isolated TTD peptide-binding pose as a point of
reference. (E) Fluorescence polarization competition of N-terminal 5-FAM-H31–20K9me3 peptides bound to UHRF1 TTD–linker (red) or
UHRF1 TTD (black; amino acids 126–280) in the presence of the indicated concentrations of UHRF1 PHD (amino acids 301–366). Error bars
represent SD for three independent experiments. (F) Histogram profiles showing NMR chemical shift changes of the UHRF1 TTD (amino
acids 126–285) upon addition of the linker (orange; amino acids 286–300), PHD (black; amino acids 310–366), or linker–PHD (blue; amino
acids 286–387). (G) Surface representation of the UHRF1 TTD–linker (PDB: 3ASK). The linker region (amino acids 286–300) is depicted as
white sticks. Significant NMR chemical shifts observed in titrations of the linker (orange), linker–PHD (blue), and both (red) are depicted.
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R295A/R296A linker mutation. Collectively, these re-
sults demonstrate that the linker region alone cannot
fully occlude the alternative H3-binding mode of the
TTD in the absence of the PHD, and they suggest that
the linker functions with the PHD in some way to
promote multivalent histone engagement by the dual
TTD–PHD module.
To gain further insight into how the PHD and linker
modulate the interaction of the TTD with the H3 tail, we
first performed a series of microsecond-scale nonequilib-
rium molecular dynamics simulations for the UHRF1
TTD–PHD and UHRF1 TTD–linker (Fig. 3B–D; Supple-
mental Movie S1; Supplemental Fig. S3). Because we were
interested in observing rare events (e.g., the dynamic
rearrangement of the PHD or linker with respect to the
TTD), we made use of an adaptive biasing potential
(Dickson 2011) to accelerate conformational sampling
and assess the free-energy landscapes. The TTD–PHD
free-energy projection was designed to correlate directly
with PHD positioning (see Materials and Methods for
details), and the position of the PHD in the crystal
structure (PDB: 3ASK) (Arita et al. 2012) is located at
the origin of the free-energy map (Fig. 3B). The projected
histograms from 10 400-nsec simulations of TTD–PHD
are shown in Supplemental Figure S3C, and a collective
average of the free-energy landscape is depicted in Figure
3B. Simulations of the TTD–PHD indicated a rugged free-
energy landscape created by nonspecific interactions
between the PHD and the TTD–linker (Fig. 3B; Supple-
mental Fig. S3C). This simulation suggests that the PHD
is ‘‘scanning’’ the TTD surface rather than residing in
a single conformation relative to the TTD. The numerous
nonspecific interactions of the PHD with the TTD result
in a compact coordination of the linker and PHD near the
TTD surface. Several metastable conformations of the
PHD in this simulation are depicted in Figure 3B, in-
cluding several poses that may physically occlude the
TTD aromatic cage that coordinates methylated H3K9
(Nady et al. 2011). Notably, closer examination of the
linker positions in the TTD–PHD simulations suggest
that these weak interactions between TTD and PHD
promote occupancy of the linker within the TTD peptide-
binding groove, as depicted in Figure 3D.
In stark contrast, the TTD–linker simulation displays a
much less complex free-energy landscape. The free-energy
estimates from five independent simulations are shown in
Supplemental Fig. S3D, and a collective average of the free-
energy landscape is depicted in Figure 3C. Here, the origin
of the coordinates corresponds to the location of the Ca
atom of S301 in the crystal structure (PDB: 3ASK) (Arita
et al. 2012). Consistently, in all five free-energy estimates,
this reference position is rarely visited. Instead, the linker
largely resides away from the TTD peptide-binding groove
(Fig. 3D). Collectively, these simulations suggest a role for
the PHD in maintaining the linker in or near the TTD-
binding groove through transient interactions with the
TTD. Hence, both the linker and PHD appear to block the
TTD from binding H3 in the alternative binding pose.
Consistent with the model described above, the free
UHRF1 PHD was able to perturb TTD–linker coordina-
tion of H3K9me3 peptides fluorescently labeled at the N
terminus (Fig. 3E). This observed competition seems to be
specific to the UHRF1 PHD, as the BPTF PHD finger had
no inhibitory effect on TTD–linker binding (Supplemen-
tal Fig. S2). However, the UHRF1 PHD was unable to
perturb the isolated UHRF1 TTD from binding this
peptide (Fig. 3E), demonstrating that the PHD inhibition
seen in Figure 3E is mediated through interaction with
the linker. Furthermore, analysis of the HSQC spectra of
UHRF1 TTD titrated with linker peptide, PHD, and
linker–PHD demonstrated that the majority of significant
chemical shift changes observed are a result of interac-
tion between the linker and the TTD (Fig. 3F; Supple-
mental Fig. S4). Both molecular dynamics and NMR
titrations suggest that the PHD does not engage in
specific interactions with the TTD (Fig. 3F; Supplemental
Fig. S4). Additionally, discreet differences in chemical
shift changes observed for the TTD in the linker and
linker–PHD titrations suggest a role for the PHD in fine-
tuning the orientation of the linker in the TTD groove.
For example, several significant chemical shift changes
for residues outside of the TTD groove (e.g., K136, N228,
K233, and E278) in the linker titration were absent in the
linker–PHD titration (Fig. 3F,G; Supplemental Fig. S4).
Furthermore, D190, shown to play key roles in the
interaction of the isolated TTD with the H3 tail (Nady
et al. 2011) and the TTD–PHD with the linker (Arita et al.
2012), displayed a significant chemical shift change in the
linker–PHD titration only (Fig. 3F,G; Supplemental Fig.
S4). Collectively, these results suggest a key role for the
PHD in preventing TTD binding to H3 peptides in the
alternative pose and reveal the importance of the co-
ordinated ensemble of TTD–linker–PHD conformations
in UHRF1 multivalent histone engagement, in which the
TTD–linker–PHD module reads the PTM status of the H3
tail from Ala 1 through Lys 9.
UHRF1 TTD–PHD multivalent histone engagement
in cis is required to facilitate DNA methylation
maintenance
We next sought to determine whether UHRF1 TTD–PHD
multivalent histone engagement is important for the
interaction of UHRF1 with bulk chromatin in cells.
Wild-type and TTD (Y188A) and PHD (D334A/E335A)
mutants of full-length UHRF1 were transiently expressed
in HeLa cells for 72 h, followed by biochemical separation
into chromatin-enriched and soluble fractions (Fig. 4A).
Consistent with our previous findings (Rothbart et al.
2012a), the TTD mutant was unable to bind bulk chro-
matin, and protein was found primarily in the soluble
fraction (Fig. 4A,C). Strikingly, similar results were obtained
with both the PHD mutant and linker mutations (R295A/
R296A) that uncouple H3 N-terminal binding or the
histone-binding properties of TTD from the PHD, re-
spectively (Fig. 4A,B). Consistently, confocal microscopy
of TTD, PHD, and linker mutants of full-length GFP-
tagged UHRF1 in HEK293 cells showed that these mu-
tants remain in the nucleus but no longer associate with
DAPI-dense pericentric heterochromatin (Fig. 3C).
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We further hypothesized that the ability of UHRF1 to
facilitate DNA methylation maintenance may require
coordinated multivalent histone engagement. We showed
previously that UHRF1 knockdown with shRNAs in
HeLa cells resulted in ;60% reduction in global 5mC
content (as analyzed by immunofluorescence), and rein-
troduction of wild-type full-length UHRF1 (but not a
TTD mutant [Y188A]) was able to restore DNA methyl-
ation in these cells (Fig. 4D; Rothbart et al. 2012a). Using
this system, we queried whether PHD histone-binding
mutants (D334A/E335A) or linker mutants (R295A/R296A)
could genetically complement for UHRF1 knockdown.
Consistent with the notion that UHRF1 DNA methyla-
tion maintenance function requires the physical associa-
tion of UHRF1 with chromatin, neither UHRF1 PHD nor
linker mutants were able to restore global DNA methyl-
ation levels in UHRF1 knockdown HeLa cells (Fig. 4D).
To further examine the role of UHRF1 histone multi-
valency in DNA methylation maintenance, we examined
the methylation status of a CpG island from the 59 end of
the intergenic spacer of ribosomal DNA (IGS-rDNA)
using methylation-specific PCR (Herman et al. 1996).
We and others have shown that DNA methylation at this
locus is regulated by UHRF1 (Bostick et al. 2007; Rothbart
et al. 2012a). Consistent with our previous findings,
knockdown of UHRF1 in HeLa cells diminished DNA
methylation at this locus, and transient expression of
wild-type (but not TTD mutant) UHRF1 partially re-
stored DNA methylation (Fig. 4E). Furthermore, neither
linker nor PHD mutants of UHRF1 were able to restore
DNA methylation at this locus (Fig. 4E). Collectively,
these results provide definitive evidence that linked histone-
binding domains of an effector protein must act coordinately
in cis to functionally engage chromatin in cells and that this
binding is critically important to mediate a fundamental
downstream epigenetic event in chromatin–DNA methyla-
tion maintenance.
Discussion
Our studies comprehensively define the contributions of
the linked TTD and PHD domains of UHRF1 to multi-
valent histone engagement. This dynamic ensemble is
likely sampling multiple conformations within the chro-
matin microenvironment until an appropriately marked
H3 tail is engaged. Notably, the SRA domain of UHRF1
Figure 4. The UHRF1 TTD–PHD functions as a single unit in cells to maintain global DNA methylation. (A,B) Western blot analysis
of wild-type (WT) and the indicated mutant forms of full-length UHRF1 in HeLa cell lysates biochemically separated into chromatin
and soluble fractions. (b-Tubulin and H3) Fractionation controls; (Mock) no DNA transfection. (C) Representative confocal microscopy
images of GFP-tagged wild-type and mutant forms of full-length UHRF1 in HEK293 cells. (GFP only) Transfection of empty GFP vector.
Bars, 10 mm. (D) Representative immunofluorescence staining for 5mC in control and UHRF1 knockdown HeLa cells after genetic
complementation with wild-type and mutant forms of full-length UHRF1. (Ctrl. KD) Nontargeted shRNA; (Mock) transfection in the
absence of DNA. Bars, 10 mm. Error is represented as 6SD. (E) Methylation-specific PCR for IGS-rDNA in control and UHRF1
knockdown HeLa cells after genetic complementation with wild-type and mutant forms of full-length UHRF1. Representative
unmethylated (U) and methylated (M) gene-specific PCR products are shown. (Ctrl. KD) Nontargeted shRNA; (Mock) transfection in
the absence of DNA. Error is represented as 6SD.
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harbors an additional chromatin-binding domain capable
of recognizing hemimethylated DNA (i.e., DNA in need
of maintenance methylation). As such, UHRF1 is one of
a few proteins known to recognize both histone and DNA
regulatory marks on chromatin. Unpublished findings
from our laboratory and recent work by Liu et al. (2013)
suggest an important role for SRA binding in cells, and
careful examination of this apparent multivalent interac-
tion with histones and DNA will be an important area of
future biochemical study.
The original posit of the ‘‘histone code’’ hypothesis
stated that there is a combinatorial code embedded in
histone tails that is read by effector proteins to mediate
a downstream biological event in chromatin (Strahl and
Allis 2000). Much research over the past decade has
provided support for this hypothesis, primarily through
the cataloging of individual reader domains recognizing
individual histone marks. Our results demonstrate that
histone-binding proteins themselves have evolved to in-
terpret complex chromatin signatures through linked and
‘‘collaborative’’ reader modules. Furthermore, the low-
affinity, but functionally independent, nature of the UHRF1
TTD, linker, and PHD domains suggests that multivalent
chromatin-binding modules may be more susceptible to
functional modulation by cellular events/factors such as
PTMs (compared with a single high-affinity interaction).
Beyond UHRF1, these studies underscore the complex-
ity of chromatin recognition likely to be harbored in
effector proteins with closely spaced reader modules
and within multiprotein complexes with multiple reader
modules. While it remains important to define the spec-
ificity of reader domains in isolation, multivalent chroma-
tin engagement by linked or coordinated reader domains is
likely to be a more physiologically relevant mode of inter-
preting the complex language of chromatin modifications.
Materials and methods
Materials
Histone peptides were synthesized, purified, and analyzed as
described (Rothbart et al. 2012b). Linker peptide (amino acids
286–300) used for NMR titrations was purchased from Genscript.
Antibodies used in this study were as follows: anti-Flag (1:5000;
Sigma, F1804), anti-b-tubulin (1:1000; Cell Signaling, 2146), anti-H3
(1:20,000; EpiCypher, 13-0001), and anti-5mC (1:100; Diagenode,
Mab-081). Human cDNAs encoding the UHRF1 TTD–PHD and
TTD–linker were cloned into pGEX-4T-1 (GE Lifesciences) as
N-terminal GST fusions for peptide microarray and fluorescence
polarization studies, expressed in Escherichia coli BL21(DE3)
using standard procedures, and purified with GST-Bind Resin
(Novagen) according to the manufacturer’s protocol. The human
UHRF1 PHD for fluorescence polarization was a gift from Y. Shi
(Harvard University). This N-terminal 6x-His fusion was expressed
in E. coli BL21(DE3) using standard procedures and was purified
with Talon Resin (Clontech) according to the manufacturer’s
protocol. An N-terminal GST fusion of the BPTF PHD was a gift
from A. Ruthenburg (University of Chicago) and was expressed
and purified as described above. Full-length human UHRF1 was
cloned into pCMV-Tag 2 (Agilent) as an N-terminal Flag fusion
and into pEGCP-C1 (gift from M. Bedford, MD Anderson Cancer
Center) as an N-terminal GFP fusion for mammalian expression.
Point mutations were generated by QuickChange site-directed
mutagenesis (Stratagene).
Histone peptide microarrays
Peptide synthesis and validation, microarray fabrication, effec-
tor protein hybridization and detection, and data analysis were
performed essentially as described (Rothbart et al. 2012b) with
the following modification. Each peptide listed in Supplemental
Table S1 was spotted in triplicate eight times per array. Triplicate
spots were averaged and treated as a single value for subsequent
statistical analysis.
Fluorescence polarization binding assays
Peptides for fluorescence polarization were synthesized essen-
tially as described (Rothbart et al. 2012b) with an additional 6-h
coupling with three equivalents of 5-carboxyfluorescein (5-FAM)
and diidopropylcarbodiimide and nine equivalents of diisopro-
pylethylamine in 1:1 volume equivalents of DMF/DMSO.
C-terminally modified peptides were synthesized with additional
orthogonally protected lysine at the C terminus after selective
deprotection of the e-amino group that lysine 5-FAM was coupled
to. Binding assays were performed in 50 mL in black flat-bottom
384-well plates (Costar) as described (Rothbart et al. 2012a).
Molecular dynamics
Adaptive biasing potential (Dickson 2011) was implemented in
GROMACS 4.5.5 (Hess et al. 2008). For the UHRF1 TTD–PHD,
the collective variables were defined as the three Cartesian
coordinates of the center of geometry of the PHD. The position
of the PHD in the crystal structure (PDB: 3ASK) (Arita et al.
2012) is located at the origin of the free-energy map (Fig. 3B). For
the TTD–linker, the collective variables were defined as the
three Cartesian coordinates of the Ca atom of residue Ser 301,
the last residue of the linker. The position of the Ser 301 Ca in
the TTD–PHD crystal structure is located at the origin of the
coordinates in Figure 3C. A grid in collective variable space is
shown for the UHRF1 TTD–PHD in Supplemental Figure S3A.
For better visibility, the visitation histograms were projected
onto a two-dimensional surface, as illustrated in Supplemental
Figure S3B. During the simulations, the UHRF1 TTD backbone
(up to residue Glu 285) was loosely restrained by a harmonic
potential to eliminate rotations and translations of the TTD,
allowing the motion of the PHD or linker to be tracked directly
as movement in the collective variable grid. To further facilitate
visualization and enable the comparison of free-energy land-
scapes, the crystal structure (PDB: 3ASK) (Arita et al. 2012) was
taken as a reference. The TTD backbones of all simulation
snapshots were aligned to the TTD backbone of the presimula-
tion structure using visual molecular dynamics (Humphrey et al.
1996) before simulation. The motion of the PHD or linker in the
simulations can thus be directly compared with the reference
structure.
The Cartesian coordinate system used here was selected so
that the origin was at the center of geometry of the TTD and the
Z-axis pointed from the origin to the center of geometry of the
PHD in the 3ASK structure (or in the case of the TTD–linker, to
the Ca atom of residue S301). The position of the PHD (Ca atom
of residue S301) was tracked as rotations around the X-axis and
Y-axis of this coordinate system. The projected histograms were
obtained by integrating over the radial component of the data at
a fixed rotation around the X-axis and Y-axis. Rotations around
the X-axis were denoted with u1, and rotations around the Y-axis
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were denoted with u2. The Euler-Rodrigues formula was used to
express the rotations around an axis.
The bias parameters were b = 0.9, c = 0.1/dt = 50 ps1, where dt
is the molecular dynamics time step. The Gaussian width was
a = 0.3 nm. All simulations were fully solvated in TIP3P water at
physiological salt conditions. For the UHRF1 TTD–PHD, the
simulation box was a dodecahedron with a minimum distance of
17 Å from the protein to the wall to allow for potential linker
extension. This resulted in a total of 70,147 atoms after adding
salt and water. For the TTD–linker, the box was a dodecahedron
with a minimum distance of 1.3 Å from the protein to the box
wall, resulting in a total of 40,830 atoms after adding salt and
water. The proteins were described by the OPLS-AA force field
(Kaminski et al. 2001). For the TTD–PHD, bond and angle
restraints were added to maintain the geometry of coordination
with zinc as described (Peters et al. 2010). System construction
included 5 nsec of isothermal–isobaric equilibration at 1 bar.
Production simulations were carried out in the canonical en-
semble with stochastic velocity rescaling (Bussi et al. 2007). Van
der Walls and direct electrostatic interactions used a 10 Å cutoff.
Long-range electrostatics were treated with the particle mesh
Ewald approach with a grid spacing of 1.6 Å. The neighbor list
was updated every five steps. Ten trajectories, each 400 nsec
in duration, were generated for the TTD–linker–PHD. Five
trajectories, each 200 nsec long, were generated for the TTD–
linker.
NMR spectroscopy and data analysis
The UHRF1 TTD (amino acids 126–285) and linker–PHD (amino
acids 288–387) were cloned into pET28- MHL and pNICCH
vectors, respectively. The UHRF1 PHD (amino acids 310–366)
was cloned into a pET15b-MHL vector using the In-Fusion
method (BD Biosciences). UHRF1 TTD was expressed and purified
as previously described (Nady et al. 2011). UHRF1 linker–PHD
and PHD were expressed in E. coli cultured in Terrific Broth
medium following overnight induction at 15°C with 1 mM
IPTG, when OD600 reached 1.5. Cell pellets were resuspended
in 20 mM Tris-HCl (pH 8.0), 0.5 M NaCl, 5% glycerol, 2 mM
Imidazole, 2 mM BME, and 1 mM PMSF. After sonication and
centrifugation, Ni-NTA agarose beads were added to the clarified
lysate, and binding to the beads was allowed to proceed for 1 h.
Bound protein was washed with 20 mM Tris-HCl (pH 8.0), 0.5 M
NaCl, 5% glycerol, and 20 mM Imidazole and eluted in similar
buffer containing 250 mM imidazole. The eluate was passed
through a size exclusion S200 16/60 column and then dialyzed
into 20 mM NaPO4 (pH 7.0), 0.25 M NaCl, and 1 mM DTT at
4°C. Chemical shift changes of residues on the UHRF1 TTD
upon titration of unlabeled linker peptide (amino acids 286–300;
Genscript), PHD, and linker–PHD,were mapped using prior
available chemical shift assignments deposited in the Biological
Magnetic Resonance Bank (BMRB) (Nady et al. 2011). 1H–15N
HSQC spectra were collected at 25°C with a Bruker Avance 500-
MHz spectrometer. Composite chemical shift changes (Dppm) were
calculated using the equation [(DppmN/6.5)
2 N + (DppmHN
2)]0.5.
ITC
Proteins and peptides were extensively dialyzed into buffer
containing 20 mM Tris-HCl (pH 8.0), 150 mM NaCl, and 5%
glycerol at 4°C. ITC measurements were performed at 20°C
with a MicroCal VP-ITC (GE Healthcare). Linker and
H3K9me2 peptides at 500 uM were titrated (25 10-mL in-
jections at 10-sec intervals) with 30 uM UHRF1 TTD. Data
points were fit to a one-site binding model using MicroCal
Origin 7.0 software.
Cell culture and manipulation
HeLa and HEK293 (American Type Culture Collection) were
cultured in MEM and DMEM (Gibco), respectively, supple-
mented with 10% FBS (PAA Laboratories), maintained in a
37°C incubator with 5% CO2 and passaged every 2–3 d. Tran-
sient transfections were performed using TurboFect (Fermentas)
according to the manufacturer’s protocol. shRNA knockdown of
UHRF1 in HeLa cells was described previously (Rothbart et al.
2012a). For GFP-UHRF1 analysis, transfected cultures of HEK293
cells growing in eight-well chamber slides (Lab-Tek) were fixed
with 4% paraformaldehyde, washed with 13 PBS, and mounted
using SlowFade Anti-fade (Life Technologies) containing DAPI.
Images were acquired using an FV1000 multiphoton inverted
confocal microscope (Olympus) at 643 magnification following
excitation with 405-nm and 488-nm single-photon lasers.
Chromatin fractionation
Chromatin and associated proteins were isolated from asynchro-
nously growing HeLa cells as described (Kuo et al. 2012; Rothbart
et al. 2012a).
DNA methylation analysis
Cells were labeled with anti-5mC (Diagenode) essentially as
described (Rothbart et al. 2012a). Images were acquired using an
FV1000 multiphoton inverted confocal microscope (Olympus)
at 603 magnification following excitation with 405-nm and
633-nm single-photon lasers. Methylation percentage was de-
rived from quantification of 5mC fluorescence normalized to
DNA fluorescence from at least four optical fields. For methyl-
ation-specific PCR analysis, genomic DNA (gDNA) was isolated
from transfected cells using a DNeasy blood and tissue kit
(Qiagen) according to the manufacturer’s protocol. Five-hundred
nanograms of gDNA was bisulfite-converted and desulphonated
using an EZ DNA Methylation-Gold kit (Zymo Research) ac-
cording to the manufacturer’s protocol. One microliter of bi-
sulfite-converted gDNA was used to amplify IGS-rDNA using
primers specific for methylated (sn primer, 59-ACGAGAGTGA
GAAGCGCGTGTTCGG-39; asn primer, 59-TCGACCTCCCG
AAATCGTACACCGAA-39) and unmethylated (sn primer, 59-AT
GAGAGTGAGAAGTGTGTGTTTGG-39; asn primer, 59-TCAA
CCTCCCAAAATCATACACCAAA-39) sequences (Esteve et al.
2006). Thirty cycles of PCR were performed using EpiMark
Polymerase (New England Biolabs) according to the manufac-
turer’s protocol using annealing temperatures of 66.6°C (meth-
ylated primer pair) and 59°C (unmethylated primer pair) before
resolving amplified DNA fragments by 12% native-PAGE.
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